Abveris on-demand webinar 02/24/2022

Anti-Idiotypic mAb Discovery Part I: Screening Strategy for Anti-Idiotypic mAb (Anti-Id) as Critical PK/ADA Assay Reagents


Ryan Kelly, Director of Business Development 

Anti-Idiotypic antibodies (anti-Id) are critical assay reagents used in PK/ADA assays for therapeutic biologics entering clinical trials. Ensuring the timely readiness of high-quality, assay-ready anti-Id is a top-priority task for all bioanalytical groups. In this webinar, the Abveris team will discuss how to de-risk anti-Id discovery in terms of screening platform and strategy selection. In this two-part webinar series, the following topics will be discussed:

1. Overview of screening technologies for anti-Id antibodies discovery

2. Do's and don'ts when planning and designing anti-Id discovery campaigns

3. Case studies of hybridoma-based and Beacon-based anti-Id campaigns targeting therapeutic biologics

Talk to a Scientist

HubSpot Video



More free webinars!

Here are more on-demand webinars that our team has put together for you


Have any questions?

Click the link below to schedule a meeting with one of our scientists!

Talk to a Scientist